Resveratrol alleviates some cardiac dysfunction indexes in an SHR model of essential hypertension.
Wu
Joseph M
JM
Department of Biochemistry and Molecular Biology, New York Medical College, New York, New York, USA. Joseph_Wu@nymc.edu
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D006332:Cardiomegaly / Q000517:prevention & control; D002316:Cardiotonic Agents; D002908:Chronic Disease; D006331:Heart Diseases / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D006333:Heart Failure / Q000188:drug therapy; D006973:Hypertension / Q000150:complications*; D009200:Myocardial Contraction / Q000187:drug effects; D051381:Rats; D011918:Rats, Inbred SHR; D000077185:Resveratrol; D013267:Stilbenes / Q000627:therapeutic use*
D000975:Antioxidants; D002316:Cardiotonic Agents; D013267:Stilbenes; D000077185:Resveratrol